webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Amino-bis-PEG3-BCN

  CAS No.:   Cat No.: BADC-01206   Purity: >98.0% 4.5  

Amino-bis-PEG3-BCN is a bi-functional ADC linker featuring PEG spacers and BCN groups for click chemistry, enhancing solubility and enabling precise dual payload conjugation in antibody-drug conjugates.

Amino-bis-PEG3-BCN

Structure of

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C47H77N5O14
Molecular Weight
936.14
Shipping
-20°C (International: -20°C)
Shipping
Store at -20 °C, keep in dry and avoid sunlight.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
IUPAC Name
Solubility
10 mm in DMSO
Shelf Life
0-4°C for short term (days to weeks), or -20°C for long term (months).
Shipping
-20°C (International: -20°C)
Storage
Store at -20 °C, keep in dry and avoid sunlight.

Amino-bis-PEG3-BCN is a bifunctional polyethylene glycol (PEG) derivative used in various biochemical applications due to its ability to link molecules and its biocompatibility. Here are some key applications of Amino-bis-PEG3-BCN:

Bioconjugation: Amino-bis-PEG3-BCN is widely used in the field of bioconjugation, where it serves to attach biomolecules such as proteins, peptides, or nucleic acids to each other. This is particularly important in the development of diagnostic assays and therapeutic agents. The PEG linker provides flexibility and reduces steric hindrance, improving the efficacy of the conjugated molecules.

Drug Delivery Systems: This compound is instrumental in the design of targeted drug delivery systems. It can be used to modify the surface of nanoparticles or liposomes, enhancing their stability and circulation time in the bloodstream. Moreover, Amino-bis-PEG3-BCN can be conjugated with targeting ligands, enabling the delivery of drugs specifically to diseased cells while minimizing side effects.

Surface Modification: Amino-bis-PEG3-BCN is used to modify surfaces of biomedical devices and implants to improve their biocompatibility and reduce biofouling. By coating surfaces with PEG, it helps prevent protein adsorption and cell adhesion, minimizing immune reactions and extending the lifespan of medical implants. This application is crucial in the development of safer and more effective medical devices.

Proteomics Research: In proteomics, Amino-bis-PEG3-BCN is employed to create homogenous protein arrays for high-throughput screening and analysis. The bifunctional PEG allows for the precise orientation and immobilization of proteins onto analytical surfaces. This enhances the accuracy and reliability of protein interaction studies, facilitating advances in biomarker discovery and drug development.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: MC-Val-Ala-PAB-PNP | Duocarmycin analog | N-[6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoyl]-L-valyl-L-alanine | Datopotamab deruxtecan | Seco-Duocamycin GA | Amino-bis-PEG3-BCN
Send Inquiry
Verification code
Inquiry Basket